• Phase

    Alumni

  • Contact person

    Jennifer Hansson, CEO

  • Email

    jennifer.hansson@akurupharma.com

  • Area

    Diagnostics, Pharma

Akuru Pharma

Akuru Pharma AB is a biomedical company focusing on exploiting the abnormal expression of transporter proteins in kidney cancer for developing novel diagnostic and treatment modalities.
CEO short bio: Jennifer Hansson, PhD i Tumor Biology from Lund University, expertise in kidney regeneration and kidney cancer.

Jennifer Hansson, PhD i Tumor Biology from Lund University, expertise in kidney regeneration and kidney cancer.

© 2020 Copyright SmiLe Incubator